Related Experiment Video
Updated: Dec 16, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale
Lena Tschiderer1, Lisa Seekircher1, Gerhard Klingenschmid1
1Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Insights
The Prospective Studies of Atherosclerosis (Proof-ATHERO) consortium aggregates data from 74 studies to understand atherosclerosis development. This large-scale meta-analysis aims to improve cardiovascular disease prediction and characterization.
Area of Science:
- Cardiovascular Research
- Epidemiology
- Medical Data Science
Background:
- Atherosclerosis is a core mechanism in cardiovascular diseases.
- Clinical tests like carotid intima-media thickness and ankle-brachial index assess atherosclerosis.
- Large-scale data aggregation is needed to understand atherosclerosis progression.
Purpose of the Study:
- To establish the Prospective Studies of Atherosclerosis (Proof-ATHERO) consortium.
- To collate individual-participant data on atherosclerosis measures, risk factors, and cardiovascular disease incidence.
- To leverage a large dataset for enhanced characterization, understanding, and prediction of atherosclerosis.
Main Methods:
- Individual-participant data meta-analysis of 74 contributing studies.
- Inclusion of studies with atherosclerosis measures, cardiovascular risk factors, and disease incidence.
- Data cleaning, harmonization, and analysis using pre-defined plans.
Main Results:
- The Proof-ATHERO consortium includes 106,846 participants from 25 countries.
- Over 830,619 person-years of follow-up, with 17,270 incident cardiovascular events recorded.
- Mean age at baseline was 59 years, with 50% female participants.
Conclusions:
- The Proof-ATHERO consortium provides a robust platform for atherosclerosis research.
- Large-scale data enables better understanding of atherosclerosis development and clinical consequences.
- This collaborative effort aims to improve prediction models for cardiovascular diseases.
Abstract:
Atherosclerosis - the pathophysiological mechanism shared by most cardiovascular diseases - can be directly or indirectly assessed by a variety of clinical tests including measurement of carotid intima-media thickness, carotid plaque, -ankle-brachial index, pulse wave velocity, and coronary -artery calcium. The Prospective Studies of Atherosclerosis -(Proof-ATHERO) consortium (https://clinicalepi.i-med.ac.at/research/proof-athero/) collates de-identified individual-participant data of studies with information on atherosclerosis measures, risk factors for cardiovascular disease, and incidence of cardiovascular diseases. It currently comprises 74 studies that involve 106,846 participants from 25 countries and over 40 cities. In summary, 21 studies recruited participants from the general population (n = 67,784), 16 from high-risk populations (n = 22,677), and 37 as part of clinical trials (n = 16,385). Baseline years of contributing studies range from April 1980 to July 2014; the latest follow-up was until June 2019. Mean age at baseline was 59 years (standard deviation: 10) and 50% were female. Over a total of 830,619 person-years of follow-up, 17,270 incident cardiovascular events (including coronary heart disease and stroke) and 13,270 deaths were recorded, corresponding to cumulative incidences of 2.1% and 1.6% per annum, respectively. The consortium is coordinated by the Clinical Epidemiology Team at the Medical University of Innsbruck, Austria. Contributing studies undergo a detailed data cleaning and harmonisation procedure before being incorporated in the Proof-ATHERO central database. Statistical analyses are being conducted according to pre-defined analysis plans and use established methods for individual-participant data meta-analysis. Capitalising on its large sample size, the multi-institutional collaborative Proof-ATHERO consortium aims to better characterise, understand, and predict the development of atherosclerosis and its clinical consequences.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Acute Coronary Syndrome III: Diagnostic Studies
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Coronary Artery Disease II: Pathophysiology

